SEC Filing Details
Document Details
Form
Filing Date
Jul 20, 2017
Document Date
May 9, 2017
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Urogen Pharma Inc.
Issuer
UroGen Pharma Ltd.
Filer
MOORIN JAY